Global perspectives on opioid use: shifting the conversation from deprescribing to quality use of medicines.

Autor: Langford AV; Sydney Pharmacy School, The University of Sydney, Sydney, New South Wales, Australia aili.langford@sydney.edu.au.; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia., Lin CC; Institute for Musculoskeletal Health, Sydney Local Health District, Sydney, New South Wales, Australia.; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia., Nielsen S; Monash Addiction Research Centre (MARC), Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Frankston, Victoria, Australia.
Jazyk: angličtina
Zdroj: BMJ quality & safety [BMJ Qual Saf] 2024 Nov 07. Date of Electronic Publication: 2024 Nov 07.
DOI: 10.1136/bmjqs-2024-017657
Abstrakt: Competing Interests: Competing interests: AVL and SN are technical advisors for the WHO guideline on balanced national policies for access and safe use of controlled medicines. AVL, C-WCL and SN were guideline development group members for the Australian evidence-based clinical practice guideline for deprescribing opioid analgesics.
Databáze: MEDLINE